Redmond, United States
Vesiflo, founded in 2012, is a United States-based innovator in the Health Care, Manufacturing, and Medical Devices sectors. This company is on a mission to redefine urinary bladder drainage with its slogan: "Manufacturer of proprietary medical devices whose mission is to reinvent urinary bladder drainage."
Specializing in solutions for women with impaired detrusor contractility (IDC), a condition often triggered by neurological diseases or injuries like stroke or multiple sclerosis, Vesiflo addresses a critical medical need. Their flagship product, the inFlow device, offers a groundbreaking alternative for women with IDC, enabling urination without daily catheterization or external drainage bags. This innovation not only restores autonomy but also mitigates complications like urinary retention and UTIs.
The company secured a $3.30M Series A investment on 10 February 2017, demonstrating investor confidence in their technology and market potential. Potential investors should consider Vesiflo as a pioneer addressing unmet medical needs with robust growth potential.
